Table 4

Laboratory data in both groups before ttt and at end of ttt

SOF LEDSOF DACLAP value
N=51N=77
Uric acid before tttMean±SD4.9±1.24.6±1.080.1135
Median54.1
IQR4–64–5
Uric acid end of tttMean±SD6.1±3.15.6±2.60.100
Median54.8
IQR4.5–64–5.5
ALT before tttMedian53580.170
IQR47–6547–74
ALT end of tttMedian28280.119
IQR25–2926–30
AST before tttMedian59670.053
IQR49–7553.5–86
AST end of tttMedian31340.055
IQR28–3329.5–37.5
Creatinine before tttMean±SD0.98±0.210.95±0.190.320
Median10.9
IQR0.8–1.10.8–1
Creatinine end of tttMean±SD1.12±0.611.11±0.560.649
Median11
IQR0.9–1.10.9–1
Platelets before tttMedian1011100.063
IQR87–12395.5–126
Platelets end of tttMedian1041150.093
IQR87–13094–129
Bilirubin before tttMedian1.11.20.982
IQR0.9–1.30.9–1.4
Bilirubin end of tttMedian1.091.20.082
IQR0.9–1.20.9–1.35
Albumin before tttMedian3.73.60.566
IQR3.5–4.23.4–3.8
Albumin end of tttMedian3.73.60.256
IQR3.4–4.23.4–3.9
INR before tttRange1–1.81–1.70.096
Mean±SD1.2±0.21.3±0.2
INR end of tttRange1–1.71–1.60.078
Mean±SD1.2±0.31.2±0.2
  • Independent samples t-test for parametric quantitative data between the two groups.

  • Mann Whitney test for non-parametric quantitative data between the two groups.

  • Significant level at italics p value <0.05.

  • ALT, alanine transaminase; AST, aspartate transaminase; DACLA, daclatsvir; INR, international normalised ratio; LED, ledipasvir; SOF, sofosbuvir; ttt, treatment.